To provide capital growth and income.
Name | % Net Assets |
---|---|
GlaxoSmithKline PLC | 5.2% |
Vodafone Group PLC | 5.2% |
Royal Dutch Shell | 5.0% |
Vodafone | 4.8% |
AstraZeneca | 4.6% |
BP | 4.3% |
British American Tobacco PLC | 3.9% |
Imperial Tobacco Group PLC | 3.6% |
British Gas | 3.2% |
Centrica | 2.3% |
Key | % Net Assets |
---|---|
GlaxoSmithKline PLC | 5.2% |
Vodafone Group PLC | 5.2% |
Royal Dutch Shell | 5.0% |
Vodafone | 4.8% |
Other | 79.8% |
Date | n/a |
---|---|
Bid | 0.00 |
Offer | 0.00 |
Currency | n/a |
Change | 0.00 |
% | n/a |
YTD change | 0.00 |
YTD % | n/a |
Fund Inception | 13/02/2004 |
---|---|
Fund Manager | n/a |
TER | 1.97 (30-Jun-2009) |
Minimum Investment | |
---|---|
Initial | 1000 |
Additional | n/a |
Savings | 50 |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.06 |
You are here: research